Pyruvate for Interference Testing

CAT:
952-K2010008P
Size:
1 mL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pyruvate for Interference Testing - image 1

Pyruvate for Interference Testing

  • Description:

    Pyruvate for Interference Testing_x000D_ Catalog number: K2010008P_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Volume/Weight: 1 mL_x000D_ pH: na_x000D_ Supplied as: Ready-to-use_x000D_ Appearance: Clear solution_x000D_ Applications: highly concentrated sodium pyruvate solution (20 mg/mL) for spiking into specimens to study the interference of pyruvate in various assays._x000D_ Storage: -20C_x000D_ Keywords: sodium pyruvate_x000D_ Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um._x000D_

    All Interference Products Brochure_x000D_

    _x000D_ Interference Testing Brochure_x000D_ _x000D_ References:_x000D_ 1: WEINSTEIN I, GUSS ML, ALTENBERN RA. Pyruvate oxidation by Pasteurella_x000D_ tularensis strains of graded virulence. J Bacteriol. 1962 May;83(5):1010-6._x000D_ _x000D_ 2: Chuang CK, Wang TJ, Yeung CY, Hsieh WS, Lin DS, Ho SC, Lin SP. Interference_x000D_ and blood sample preparation for a pyruvate enzymatic assay. Clin Biochem. 2006_x000D_ Jan;39(1):74-7._x000D_ _x000D_ 3: Fujita Y, Ito M, Kojima T, Yatsuga S, Koga Y, Tanaka M. GDF15 is a novel_x000D_ biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases._x000D_ Mitochondrion. 2015 Jan;20:34-42._x000D_ _x000D_ 4: Hibi M, Horinouchi N, Tu W, Soong CL, Ito M, Segawa T, Mu X, Hagishita T,_x000D_ Yokozeki K, Shimizu S, Ogawa J. Breeding of a cyclic imide-assimilating_x000D_ bacterium, Pseudomonas putida s52, for high efficiency production of pyruvate._x000D_ Biosci Biotechnol Biochem. 2013;77(8):1650-4._x000D_ _x000D_ 5: HUCKABEE WE. Relationships of pyruvate and lactate during anaerobic_x000D_ metabolism. II. Exercise and formation of O-debt. J Clin Invest. 1958_x000D_ Feb;37(2):255-63._x000D_ _x000D_ 6: MCMILLAN PJ, MORTENSEN RA. The metabolism of brain pyruvate and acetate in_x000D_ the tricarboxylic acid cycle. J Biol Chem. 1963 Jan;238:91-3._x000D_ _x000D_ 7: HUCKABEE WE. Relationships of pyruvate and lactate during anaerobic_x000D_ metabolism. III. Effect of breathing low-oxygen gases. J Clin Invest. 1958_x000D_ Feb;37(2):264-71. d_x000D_ _x000D_ 8: GUGGENHEIM K, MAYER J. Studies of pyruvate and acetate metabolism in the_x000D_ hereditary obesity-diabetes syndrome of mice. J Biol Chem. 1952_x000D_ Sep;198(1):259-65._x000D_ _x000D_ 9: Turner K, Martin KL, Woodward BJ, Lenton EA, Leese HJ. Comparison of pyruvate_x000D_ uptake by embryos derived from conception and non-conception natural cycles. Hum_x000D_ Reprod. 1994 Dec;9(12):2362-6._x000D_ _x000D_ Products Related to Pyruvate for Interference Testing: Interference Products
  • Short Description:

    Catalog Number: K2010008P (1 mL)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5